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PCardiovascular Effects of Aging
ffects of Normal Aging on Left
entricular Lusitropic, Inotropic, and
hronotropic Responses to Dobutamine
aul S. Hees, PHD,* Jerome L. Fleg, MD,† Zulfiqar A. Mirza, MD,‡ Sujood Ahmed, MD,§
ynthia O. Siu, PHD, MBA, Edward P. Shapiro, MD*
altimore, Maryland; Dayton, Ohio; Birmingham, Alabama; and Ringoes, New Jersey
OBJECTIVES The purpose of this study was to characterize how aging impacts the left ventricular (LV)
functional reserve.
BACKGROUND Early diastolic LV filling slows markedly with advancing age, but the effects of -adrenergic
stimulation on filling, and its major determinant, relaxation, have not been investigated in an
aging population. Although the responses of contractility and heart rate to catecholamines
reportedly diminish with age, the effect of age on the responses to steady-state dobutamine
infusions is unclear.
METHODS Groups of younger (40  10 years, n  26) and older (68  11 years, n  24) normal adult
patients were studied at baseline and at three progressive dobutamine infusion dosages (5, 10,
and 20 g/kg/min). The LV function was evaluated by two-dimensional and Doppler
echocardiography. Myocardial relaxation was evaluated from cardiovascular magnetic reso-
nance (CMR)-based , a preload-independent surrogate for  . Effective LV pump-function
index (PFi), defined as systolic blood pressure/end-systolic LV diameter, was measured.
RESULTS Both groups showed expected dose-dependent increases in heart rate and LV systolic
function, diastolic function, and relaxation. Early LV filling reserve was much greater in
younger than older patients (E-wave increase from baseline to highest dose, 24.0 vs. 9.5 cm/s,
p  0.004), although the dose responses of  were indistinguishable (0.18% vs. 0.19%/ms,
p 0.22). Whereas dobutamine caused a significantly greater increase of PFi in younger than
older patients (30.1 vs. 15.6 mm Hg/cm, p  0.0001), there was no difference in heart rate
augmentation (37 vs. 38 beats/min, p  0.94).
CONCLUSIONS Aging is accompanied by a blunted inotropic but preserved chronotropic response to
steady-state dobutamine infusion. Although LV filling reserve declines with age, relaxation
reserve does not. (J Am Coll Cardiol 2006;47:1440–7) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.052Cardiology Foundation
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nn age-associated decline in resting early left ventricular
LV) diastolic function in normal adults is well documented
sing Doppler echocardiographic methods such as E- and
-wave velocities, E-wave deceleration, and isovolumic
elaxation time. Despite the decline in diastolic function
ith age, studies that have examined inotropic measures
uch as fractional shortening or velocity of circumferential
hortening at rest have seen little or no decline with
dvancing age (1,2). As important as resting measures of LV
erformance is the ability of the heart to show reserve
apacity in response to stress. -adrenergic stimulation by
atecholamine administration is commonly used as a phar-
acologic stress to determine the presence of significant
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altimore, Maryland; ‡Department of Medicine and Division of Cardiology, School
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ivision of Cardiology, University of Alabama at Birmingham, Birmingham, Ala-
ama; and Data Power Inc, Ringoes, New Jersey. This study was supported by the
ational Heart, Lung, and Blood Institute (R01 HL46223), the National Institute on
ging (R01 AG023624-02), and intramural funds of the NIA/NIH.e
Manuscript received February 8, 2005; revised manuscript received November 1,
005, accepted November 7, 2005.oronary artery disease, and can be used to assess lusitropic,
notropic, and chronotropic reserves.
The impact of normal aging on LV lusitropic functional
esponse to -adrenergic agonists is unknown. Diastolic
unction is determined by a complex blend of myocardial
elaxation, load, and stiffness; recently developed non-
nvasive methods for characterizing the response of each of
hese to adrenergic stimulation have not been applied
oward the study of the aging heart. Numerous studies have
hown a reduced inotropic functional response to isoproter-
nol, a potent stimulant of both 1 and 2 adrenergic
eceptors, with advanced age (3–7). In these studies, chro-
otropic responsiveness has also decreased with normal
ging. However, it is unclear whether this difference in heart
ate effect is mediated by age-associated decline in the
aroreceptor response to 2-mediated vasodilation rather
han by intrinsic decreases in 1-adrenergic responsiveness.
The current study was designed to characterize how age
mpacts the cardiac lusitropic, inotropic, and chronotropic
esponses to -adrenergic stimulation in carefully screened
ormal adults. Diastolic and systolic LV performance was
valuated by echocardiographic techniques and recently
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April 4, 2006:1440–7 Age and the LV Response to Dobutamineeveloped and validated cardiovascular magnetic resonance
CMR) methods (8). The potential for a confounding
aroreceptor effect on chronotropic response was minimized
y using steady-state dobutamine infusions, which provide
elatively selective agonism of 1 rather than 2 adrenergic
eceptors.
ETHODS
atients. Normal volunteers from the Baltimore Longitu-
inal Study of Aging (BLSA) were recruited for this study.
his cross-sectional sample of 50 individuals ranged in age
rom 23 to 90 years, with a median age of 53 years. They
ere healthy, ambulatory, and community-dwelling, with
o evidence of acute or chronic cardiovascular disease, no
ebilitating illnesses, and no cardiovascular medications. In
ddition, all individuals were screened for the absence of
eart disease by medical history, physical examination,
esting and exercise electrocardiogram, and, if 40 years of
ge, thallium scintigraphy. Individuals had a seated blood
ressure 160/95 mm Hg on current physical examination.
he median age was used to divide the sample into a
ounger (40  10 years) and older (68  11 years) cohort
or performing age comparisons.
obutamine protocol. Identical stress protocols were used
or magnetic resonance imaging and echocardiographic
xaminations on successive days. To ensure equivalent status
t both examinations, they were performed at the same time
f day on patients kept fasting from midnight until the test
as completed. In addition, it was ensured that there was no
hange in medications between the two examinations. Data
ere acquired at baseline, and during 6-min stages of
obutamine infusions of 5, 10, and 20 g/kg/min. Blood
ressure, electrocardiogram, and transcutaneous oxygen sat-
ration were monitored throughout the dobutamine imag-
ng studies. Administration of dobutamine at a steady rate
as chosen because it avoids the confounding effects of the
aroreflex and is concordant with the usual diagnostic and
herapeutic regimens for catecholamine infusion. Also, steady-
tate conditions are preferable for conducting CMR data
cquisitions, which are lengthy.
MR cine imaging. Cardiac magnetic resonance tissue
agging has allowed precise characterization of LV systolic
nd diastolic performance. The CMR-based LV recoil rate
) has been shown to be a noninvasive, preload-independent
Abbreviations and Acronyms
CMR  cardiovascular magnetic resonance
LV  left ventricular
PFi  pump function index
SBP  systolic blood pressure
  slope of diastolic LV myocardial recoil; CMR-
based recoil rate
  time constant of diastolic LV pressure decrease;
measure of relaxationredictor of LV relaxation (9). The net difference in short-axis awist between base and apex experienced throughout the
ardiac cycle is defined as torsion. The rapid reversal of
orsion in diastole is defined as recoil, with , defined as the
lope of isovolumic early recoil. Prior studies in our labora-
ory have shown that  correlates closely with invasively
etermined . Advances in CMR methods, particularly
ncreased imaging speed, allow the performance of staged
harmacologic stress studies (10–12).
Tagged cine images were acquired on a Siemens Vision
.5-T clinical imaging system (Siemens Medical Systems,
rlangen, Germany). A segmented k-space (segmentation
evel  3) fast-gradient echocardiographic pulse sequence
ith view sharing was used to obtain prospectively gated
reath-hold gradient echocardiographic cines, with radial
ags applied at end diastole. Intrinsic cycle time was 30 ms,
hich, with view-sharing, resulted in cine temporal resolu-
ion of 20 ms. Rectangular field of view was used to limit
cquisition time, with a 2:1 acquisition ratio of readout to
hase encode resolution, resulting in a 256  256 image
atrix. At each dobutamine dose, five separate cines were
cquired; basal, mid-ventricular and apical short axis planes,
nd two-chamber and four-chamber long-axis planes.
Contouring and deformation analysis were performed
ffline using software developed in-house (Cardiac Image
rocessing System). Recoil rate () is defined as the slope of
he line fit to recoil points measured during isovolumic
elaxation, expressed as percent maximum torsion per mi-
rosecond.
chocardiography. A variety of LV structural and func-
ional indices were evaluated from echocardiographic stress
xaminations, obtained using a 3.5-MHz imaging trans-
ucer on a Phillips Sonos 5500 system (Phillips Medical
ystems, Best, the Netherlands). Doppler echocardiography
as used to measure transmitral velocities and physiological
ntervals using standard techniques, tissue Doppler long-
xis mitral annulus velocities at the lateral wall, and color
-mode estimates of the velocity of propagation of the LV
lling wave; two-dimensional echocardiography was used to
easure LV dimensions, and an LV pump function index
PFi), defined as systolic blood pressure (SBP)/LV end-
ystolic cavity diameter, was calculated. Echocardiographic
easurements were performed offline using personal
omputer-based ImageVue DCR software (Eastman-
odak, Rochester, New York).
tatistical analysis. Statistical analyses were performed
sing the personal computer-based application StatView
SAS Institute Inc., Cary, North Carolina). Student t test
as used to compare group measures at baseline. To
xamine the effect of age on structure and function, as well
s possible gender interactions, repeated-measures analysis
f variance was performed to compare dobutamine dose
esponses in the younger versus older groups. As a further
est to evaluate the age dependence of catecholamine re-
ponse, the change from baseline measures induced by
aximum dose was regressed on age using linear regressionnalysis. A two-tailed p value  0.05 was defined as
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LV  left ventricular.
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tandard deviation.
ESULTS
aseline age group differences. Basic descriptive group
haracteristics are shown in Table 1. The age groups did not
iffer significantly in either body mass index or body surface
rea. At baseline, younger patients had lower SBP and pulse
ressure than older patients (see Table 2 for p values), but
he groups had nearly identical heart rates.
Baseline echocardiographic and CMR indices of cardiac
tructure and function are compared in Table 2. Linear
easures of LV dimension are indexed to body height;
ounger patients had generally thinner LV walls at end-
iastole, including lower septal wall (0.56  0.06 cm/m vs.
.62 0.07 cm/m, p 0.004) and posterior wall (0.55 0.07
m/m vs. 0.61  0.07 cm/m, p  0.005) thicknesses; and
arger LV cavity diameter (2.73  0.27 cm vs. 2.53  0.25
m, p  0.013). Several baseline measures indicated better
arly diastolic function and lesser late diastolic function in
ounger than in older patients, including greater peak E-wave
elocity (84  22 cm/s vs. 73  17 cm/s, p  0.03); shorter
eceleration time of early transmitral flow (187  33 ms vs.
25  61 ms, p  0.01); lower peak A-wave velocity (64 
1 cm/s vs. 79  17 cm/s, p  0.0004); and lower overall
-wave velocity-time integral (5.7 1.2 cm vs. 7.4 2.3 cm,
 0.001). Isovolumic relaxation time was shorter in
ounger (79  15 ms vs. 85  15 ms, p  0.04), whereas
yocardial  at baseline was not significantly different
etween the younger and older groups, respectively (0.61 
.20%/ms vs. 0.55  0.16%/ms, p  0.17).
Resting heart rate was similar in younger and older
atients, (69  10 beats/min vs. 68  7 beats/min);
owever, PFi was lower in younger patients (39  7 mm
g/cm vs. 47  12 mm Hg/cm, p  0.008); and younger
atients had a shorter ejection time (285 17 ms vs. 308
3 ms, p  0.0003). In contrast, thickening of the septum
29  6% vs. 23  6%, p  0.01) and posterior free wall
30  6% vs. 24  7%, p  0.02) were higher in younger
han in older patients. No significant difference in endocar-
ial fractional shortening was seen between age groups at
aseline.
able 1. Subject Characteristics
Younger Group,
Age < Median
(n  26)
Older Group,
Age > Median
(n  24)
ge (yrs) 40  10 68  11
women 42 58
MI 26.0  4.6 25.5  3.4
SA (m2) 1.90  .25 1.80  25
BP (mm Hg) 123  17 128  14
BP (mm Hg) 73  10 71  9
P (mm Hg) 49  16 57  12
R (beats/min) 69  10 68  7MI  body mass index; BSA  body surface area; DBP  diastolic blood pressure;
R  heart rate; PP  pulse pressure; SBP  systolic blood pressure.able 2. Comparisons of Baseline Values Between Age Groups
Younger
Group,
Age < Median
Older
Group,
Age > Median
p
t Test
Baseline Baseline Baseline
hronotropy
Heart rate (beats/min) 69  10 68  7 0.7615
lood pressure
Systolic blood pressure
(mm Hg)
123  17 128  14 0.2440
Diastolic blood pressure
(mm Hg)
73  10 71  9 0.4076
Pulse pressure (mm Hg) 49  16 57  12 0.0688
V structure
Diastolic septal thickness
index* (cm/m)
0.56  .06 0.62  .07 0.0031
Diastolic post wall
thickness index*
(cm/m)
0.55  .07 0.61  .07 0.0045
Diastolic cavity diameter
index* (cm/m)
2.73  .27 2.53  .25 0.0128
Left atrial linear
dimension index*
(cm/m)
1.95  .29 2.17  .37 0.0320
V pump function
Pump function index
(mm Hg/cm)
39.4  7.2 46.5  11.5 0.0080
End systolic cavity
diameter index*
(cm/m)
1.91  .32 1.70  .25 0.0106
Septal thickening (%) 29  6 23  6 0.0092
Posterior wall thickening
(%)
30  6 24  7 0.0172
Annular velocity in
systole (cm/s)
12.2  4.3 12.5  8.6 0.9175
Endocardial fractional
shortening (%)
30  6 33  9 0.1401
Velocity of
circumferential
shortening (%/ms)
0.10  .02 0.10  .03 0.6360
V relaxation
Recoil rate (%/ms) 0.61  .20 0.55  .16 0.1681
Velocity propagation
(cm/s)
56.8  16.5 50.9  23.6 0.3958
Annular velocity in early
diastole (cm/s)
18.1  7.0 13.0  9.2 0.0941
Annular velocity in late
diastole (cm/s)
13.2  5.9 14.2  4.9 0.6525
V filling
Peak E-wave filling
velocity (cm/s)
84.3  21.9 72.8  17.3 0.0258
Peak A-wave filling
velocity (cm/s)
63.6  10.9 79.2  16.9 0.0004
Deceleration time (ms) 187  33 225  61 0.0099
Deceleration rate (cm/s2) 477  164 351  112 0.0012
E-wave velocity-time
integral (cm)
12.1  3.1 11.1  3.5 0.2855
A-wave velocity-time
integral (cm)
5.7  1.2 7.4  2.3 0.0010
Isovolumic relaxation
time (ms)
78.5  15.3 84.6  14.9 0.0400
Measures indexed to height in meters. Bold values indicate statistical significance at
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April 4, 2006:1440–7 Age and the LV Response to Dobutamineose responses of young versus older groups to dobu-
amine. Dobutamine dose response differences between
ounger and older patients are shown in Table 3. In
ddition to the observed deficit in early diastolic function of
lder patients at baseline, they also showed a markedly
able 3. Comparisons of Responses to Graded Dobutamine Infu
Dose Response (Mean Change F
75 g/kg/min 10 g/kg/min
Y O Y O
hronotropy
Heart rate (beats/min) 1 1 9 9
lood pressure
Systolic blood pressure
(mm Hg)
4 5 23 15
Diastolic blood pressure
(mm Hg)
0 2 3 1
Pulse pressure (mm Hg) 4 4 19 17
V structure
Diastolic septal thickness
index* (cm/m)
0.01 0.01 0.02 0.02
Diastolic post wall thickness
index* (cm/m)
0.01 0.02 0.01 0.03
Diastolic cavity diameter index*
(cm/m)
0.03 0.00 0.06 0.00
Left atrial linear dimension
index* (cm/m)
0.05 0.08 0.00 0.11
V pump function
Pump function index
(mm Hg/cm)
4.4 4.1 20.3 8.0
End systolic cavity diameter
index* (cm/m)
0.09 0.07 0.34 0.10
Septal thickening (%) 0 2 1 1
Posterior wall thickening (%) 1 2 3 1
Annular velocity in systole
(cm/s)
2.4 0.3 6.3 5.1
Endocardial fractional
shortening (%)
5 3 13 4
Velocity of circumferential
shortening (%/ms)
0.03 0.02 0.08 0.05
V relaxation
Recoil rate (%/ms) 0.07 0.05 0.10 0.07
Velocity propagation (cm/s) 15.9 18.8 22.4 22.8
Annular velocity in early
diastole (cm/s)
0.2 0.5 1.6 1.4
Annular velocity in late diastole
(cm/s)
0.2 2.2 1.4 4.0
V filling
Peak E-wave filling velocity
(cm/s)
11.2 5.6 21.7 8.3
Peak A-wave filling velocity
(cm/s)
4.8 2.0 12.0 12.4
Deceleration time (ms) 16 25 12 24
Deceleration rate (cm/s2) 4 16 87 4
E-wave velocity-time integral
(cm)
1.8 2.1 3.6 2.1
A-wave velocity-time integral
(cm)
0.4 0.4 0.6 1.2
Isovolumic relaxation time (ms) 3.8 9.3 13.7 16.8
Measures indexed to height in meters. Bold values indicate statistical significance a
LV  left ventricular; m  slope of fit line; O  older group, age  median; r uted augmentation of peak E-wave velocity (24.0 vs. o9.5 cm/s, younger vs. older patients, p  0.004) (Fig. 1)
nd velocity-time integral (3.2 vs. 0.2, p  0.003) in
esponse to dobutamine; both of these measures also showed
nhancements that were significantly correlated with age. No
ge difference in peak A-wave velocity augmentation was
Y Versus O
Baseline)
ANOVA
(Repeated Measures)
Regression (Change at
Maximum Dose)
g/kg/min p p p m r p
O Age Dose Inter Age Age Age
38 0.6877 <0.0001 0.9422 0.102 0.103 0.5225
24 0.9870 <0.0001 0.0079 0.339 0.312 0.0473
2 0.1017 0.7118 0.0101 0.188 0.331 0.0370
27 0.3558 <0.0001 0.3177 0.146 0.155 0.3394
.02 0.06 0.0002 0.0007 0.1274 0.002 0.342 0.0216
.03 0.06 0.0002 0.0006 0.5619 0.001 0.196 0.2016
.10 0.09 0.0196 0.0032 0.5671 0.000 0.021 0.8911
.05 0.17 0.2185 0.0002 0.0567 0.003 0.218 0.1664
.1 15.6 0.7697 <0.0001 0.0002 0.345 0.436 0.0100
.41 0.24 0.2983 <0.0001 0.0064 0.009 0.386 0.0105
1 0.0003 0.8670 0.1638 0.086 0.196 0.2074
0 0.0002 0.4192 0.5386 0.013 0.028 0.8587
.3 8.6 0.9339 0.0012 0.8690 0.104 0.139 0.4908
7 0.5971 <0.0001 0.0060 0.002 0.332 0.0295
.12 0.09 0.1872 <0.0001 0.1121 0.001 0.273 0.0888
.18 0.19 0.3359 <0.0001 0.2203 0.002 0.151 0.3857
.1 20.6 0.4658 <0.0001 0.9865 0.049 0.033 0.8607
.9 1.0 0.0138 0.4897 0.9919 0.005 0.011 0.9562
.5 4.0 0.1726 0.0078 0.4423 0.048 0.167 0.3945
.0 9.5 0.0011 <0.0001 0.0033 0.486 0.483 0.0006
.9 22.2 0.0010 <0.0001 0.7308 0.044 0.059 0.6907
6 0.0004 0.0300 0.3545 0.510 0.142 0.3357
59 <0.0001 0.0048 0.2046 0.064 0.006 0.9677
.2 0.2 0.0345 <0.0001 0.0023 0.117 0.481 0.0006
.1 1.6 0.0003 <0.0001 0.5090 0.009 0.093 0.6907
.5 27.4 0.6736 <0.0001 0.1684 0.311 0.390 0.0097
el of p  0.05.
lation coefficient of linear regression; Y  younger group, age  median.sion,
rom
20
Y
37
40
4
36
0
0
0
0
30
0
3
2
7
14
0
0
21
0
1
24
20
11
73
3
1
18bserved (Fig. 2). Whereas the shortening of isovolumic
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Age and the LV Response to Dobutamine April 4, 2006:1440–7elaxation time in response to dobutamine was not signifi-
antly different between age groups, the shortening of
sovolumic relaxation time induced by maximal dose de-
reased significantly with age (r  0.39, p  0.01). No
easure of LV relaxation, including  (Fig. 3), LV flow
elocity propagation, and early diastolic tissue Doppler
itral valve annulus velocity, showed a different augmenta-
ion pattern between younger and older patients.
A generally reduced pump function dose response to
atecholamine infusion was seen in older patients (Fig. 4),
ncluding LV end systolic cavity dimension (0.41 vs.
0.24 cm/m, younger vs. older patients, p  0.007) and
ndocardial fractional shortening (14% vs. 7%, p 
.006), and again, these results were reinforced by a signif-
cant correlation between induced changes in pump function
nd age (Table 3). The augmentation in SBP was signifi-
antly greater in younger than older patients (40 vs. 24
igure 1. Early diastolic left ventricular filling, as indicated by Doppler
chocardiographic peak E-wave velocity (E-peak), is lower in the older
open bars) than younger (solid bars) group at baseline. Moreover, E-peak
ncreases with dobutamine dose in the younger but not the older group
interaction p  0.004). Error bars  1 SEM.
igure 2. Late diastolic left ventricular filling, as indicated by Doppler
chocardiographic peak A-wave velocity (A-peak), increases with dobu-
amine dose in both groups. Whereas younger (solid bars) patients have
ower overall A-peak than older (open bars) patients, the dose response to
obutamine is indistinguishable between the two age groups. Error bars 
SEM.
d
(m Hg, p  0.008). Thus, the PFi was inversely correlated
ith age. Percent wall thickening, however, increased sim-
larly with dose in both groups. Despite the generally greater
V pump function response showed by younger patients, no
uch age difference was seen in chronotropic responsiveness
o catecholamine infusion; heart rate increased in younger
atients from 69 to 106 beats/min and in older patients
rom 68 to 106 beats/min (Fig. 5).
Because there was a modest, non-significant difference in
ender composition of the two age groups, (42% vs. 58%
emale in younger vs. older groups), we tested for interac-
ions between age and gender that might affect the signif-
cance of observed differences in dobutamine responses. No
nteraction was found except in the response of SBP (p 
.05 for gender-age interaction response), where the higher
ercentage of women in the older group, along with a lower
ose response among women (27 vs. 38 mm Hg for
en, p  0.008), contributed to the observed reduction in
igure 3. Left ventricular relaxation, as indicated by magnetic resonance
maging recoil rate (r) expressed as percent of maximum torsion per
icrosecond, increases generally with dobutamine dose; this dose response
s indistinguishable between the two age groups. Solid bars  younger;
pen bars  older. Error bars  1 SEM.
igure 4. Although pump function index (PFi) defined as systolic blood
ressure (SBP)/left ventricular (LV) end-systolic cavity dimension, is lower
n the younger group (solid bars) at baseline, its response to increasing
oses of dobutamine is greater than in the older group (open bars)
interaction p  0.0001). Error bars  1 SEM.
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April 4, 2006:1440–7 Age and the LV Response to Dobutamineose response with age. The much greater enhancement in
Fi of younger than older patients did not share this gender
nteraction.
ISCUSSION
hese data show that the LV response to steady-state
obutamine infusion differs in normal young and older
dults in several ways. Diastolic function, particularly early
V filling, augments to a greater extent in response to
ncreasing dobutamine dose in young individuals, although
his cannot be attributed to greater augmentation of LV
elaxation. Several measures suggest a greater inotropic
esponse to -adrenergic stimulation in younger individuals,
lthough the chronotropic response of older and younger
atients is virtually indistinguishable in these healthy vol-
nteers.
elation of age to lusitropic effects of dobutamine. Early
iastolic filling is dependent on myocardial relaxation. The
educed early diastolic filling rates seen in elderly patients
re usually ascribed to age-related changes in the rate of LV
ressure decrease. However, recent studies do not support
his concept. Using invasive methods, Yamakado et al. (13)
eported measures of relaxation by micromanometer in 55
ormal patients ages 20 to 77 years, and  was not related to
ge. These findings are consistent with our recent study
sing echocardiography (filling wave velocity propagation
nd tissue Doppler echocardiography) and CMR () mea-
ures in a similarly normal sample of 122 patients, also
erived from the BLSA trial (8). Specifically we found no
ge-associated change in relaxation, despite the decline in
arly LV filling with age.
To further understand the effects of age on diastolic
unction, the current study examined filling and relaxation
eserve in response to catecholamine stress. Here, the
bserved group differences in early peak filling rate augmen-
ation were evidently not mediated through changes in
elaxation, measured by several methods, including , LV
igure 5. Heart rate is similar at rest and increases with dobutamine dose,
ith nearly identical dose responses in the two age groups. Solid bars 
ounger; open bars  older. Error bars  1 SEM.ow velocity propagation, and early diastolic tissue Doppler mitral valve annulus velocity. In each of these measures of
elaxation, indistinguishable augmentation patterns to do-
utamine were seen in young and older individuals, despite
markedly reduced enhancement pattern of early filling
een in older patients.
Left ventricular filling is mediated by transmitral hemo-
ynamics. If ventricular relaxation does not drive the atrial-
entricular pressure gradient, preload emerges as the most
easonable explanation. Lenihan et al. (14) studied the effect
f altering load (with nitroprusside and phenylephrine) and
ontractility (with dobutamine) on the early diastolic atrio-
entricular gradient and on LV filling in patients with
iastolic dysfunction caused by hypertension. They found
hat changes in the atrioventricular gradient were deter-
ined primarily by loading conditions and were not impor-
antly influenced by LV relaxation. For example, dobut-
mine reduced early filling velocities in their study
espite a distinct augmentation in relaxation, because
mall declines in LA pressure caused by venodilation had
much greater impact on filling than did the rate of LV
ressure decrease. A similar interaction between relax-
tion, preload, and filling was probably operative in our
lder cohort. However, these individuals experienced
nly reduced filling augmentation rather than an actual
lling decline, perhaps because they manifested only
ormal age-related diastolic dysfunction rather than the
ore marked dysfunction induced by disease.
elation of age to inotropic and chronotropic effects of
obutamine. The response to -adrenergic stimulation by
soproterenol, including sharply increased heart rate and
ontractility, has generally been found to be attenuated in
lder individuals (3–7). Our findings differed in part from
his pattern; as anticipated, the older group did show a lesser
esponse in PFi to dobutamine, whereas the chronotropic
ffects were virtually identical between groups. Because the
hronotropic response is influenced by both sympathetic
nd parasympathetic nervous systems, the difference in
ndings in various studies may be attributable to a different
ontribution of parasympathetic baroreceptor reflexes in
ach. Stratton et al. (15) reported that vagally mediated
arasympathetic effects on heart rate decreases with age.
his might be caused by age-related arterial stiffening,
uting the baroreceptor reflex. Therefore, prior reports of
iminished chronotropic response to -agonists with aging
ay reflect in part diminished parasympathetic withdrawal
n response to 2-mediated vasodilatation rather than solely
iminished sympathetic response. In support of this con-
ept, in pithed rats, in which the baroreflex was eliminated,
he age-related deficit in heart rate response to a catechol-
mine bolus seen in intact animals was eliminated (16). In
ur study we used dobutamine, which has only weak 2
ctivity, and is thus less likely to cause baroreflex-mediated
achycardia. In addition, the drug was administered as a
ustained infusion, allowing time for the baroreceptor re-
ponse to extinguish before responses were measured. Thus,
easurements immediately after bolus administration of
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Age and the LV Response to Dobutamine April 4, 2006:1440–7atecholamines might reflect a transient baroreceptor-
ediated deficit in heart rate response in the elderly, which
ould then ameliorate when the longer-term infusion allows
he full, steady-state response to occur. In support of this
oncept, Poldermans et al. (17) also found no age-associated
eficit in chronotropic response to staged, steady-state
nfusions of dobutamine in patients referred for diagnostic
harmacologic stress testing, paralleling our own findings.
otably, isoproterenol was used in all (3–7) studies that
howed a reduced chronotropic response to -agonists in
ged individuals.
There are several possible explanations for the dissociated
notropic and chronotropic 1 adrenergic responses with
ge. First, these results raise the possibility that distinct 1
eceptor subtypes modulate inotropic versus chronotropic
esponses, and aging may have a selective effect on certain
ubtypes. Using the noncardioselective -receptor blocker
epindolol with increasing isoproterenol dose in a small
ohort of normal men, Bonelli (18) effected selective block-
de of positive inotropic and positive chronotropic re-
ponses. These dissociated inotropic and chronotropic dose
esponses were interpreted as evidence that distinct 1
eceptors mediate specific effects on heart rate and positive
notropy.
Second, there may be an age-related difference in the
istribution of -receptors in the right atrium versus the left
entricle, explaining differential chronotropic and inotropic
esponses to -adrenergic stimulation. This seems to be the
ase in chronic hypoxia, in which a similar maintained
hronotropic but reduced inotropic response to cat-
cholamines was seen by Doshi et al. (19).
tudy limitations. The dobutamine regimen chosen for
his study is somewhat conservative when compared with
ommon clinical protocols. However, inotropic parameters
uch as percent thickening, percent shortening, fractional
hortening, and ejection fraction tend to plateau at or near
hese lower dobutamine doses. This effect is likely caused by
he reduced preload, from venodilation, which occurs with
obutamine infusion at higher doses. Our decision to limit
he drug dose was influenced by this plateau effect and also
y our desire to limit potential adverse effects, such as
rrhythmias, that might occur in normal volunteers during
he time that they were undergoing CMR, particularly
ecause rigorous electrocardiographic monitoring is not
ossible in the magnetic environment.
Another limitation of the current study is that brachial
rtery measurements of SBP do not necessarily reflect
ressure in the LV, especially given possible age differ-
nces in the effect of dobutamine on pulse wave ampli-
cation. Therefore, it is more accurate to consider the
atio of SBP/LV systolic diameter as a relevant index of
ffective LV pump function rather than a true measure of
V contractility, for which it is an imperfect surrogate.
he fact that other measures of LV pump function that
o not incorporate peripheral blood pressure, most nota-
ly LV systolic diameter and fractional shortening, alsohowed reduced responses to dobutamine in the older
roup, does, however, support the concept of an age-
ssociated deficit in contractility.
ONCLUSIONS
ardiovascular responsiveness to graded dobutamine stress
aries with normal aging. The CMR-based LV recoil rate
), a novel, noninvasive surrogate for , does not indicate a
ignificant loss of relaxation reserve in response to dobu-
amine with normal aging, which is similar to results
btained using direct micromanometer catheter measures
14). However, early LV filling reserve is significantly
iminished with age, despite preserved myocardial relax-
tion reserve. These findings suggest, therefore, that age-
elated filling differences may reflect an altered left
trium-LV pressure gradient, through age-related changes
n load or timing rather than simply altered relaxation.
ormal aging is also accompanied by a blunted inotropic
ut not chronotropic response to steady-state exogenous
-adrenergic stimulation.
The steady-state response to graded dobutamine infusion
rovides insight into -adrenergic responsiveness without
he confounding influence of the baroreflex; this is in
ontrast to bolus doses, in which the baroreflex dominates.
he clinical relevance of this distinction lies in the oppor-
unity to determine whether the steady-state dobutamine
oses used for diagnostic and therapeutic purposes should
e altered in older individuals. The current findings, cou-
led with those of Poldermans et al. (14), suggest no need
or such a dobutamine dose adjustment to increase heart
ate. However, older patients may require larger doses than
ounger patients to achieve similar increases in pump
erformance.
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